FDA says new regulatory pathway is needed for CBD products

The FDA has said new regulatory pathway is needed for CBD products so that regulatory oversight can manage food safety risks.

Related Keywords

Janet Woodcock ,Drug Administration ,Grace Galler ,Mayo Clinic ,Principal Deputy Commissioner ,